Pfizer gets obesity drug approval in China shortly after buying local rights
辉瑞在收购manbetx3.0 本土权益后不久获批肥胖药物在华上市

Pfizer was a late arrival to the obesity gold rush, but it just hit its first seam.
辉瑞虽在肥胖治疗的淘金热中起步较晚，但刚刚挖到了第一条富矿脉。